We develop MRI quantitative imaging biomarkers for precision diagnosis and treatment
Quantitative MRI Biomarkers
Medimagemetric LLC is founded on technical and clinical research development of MR Imaging-based biomarkers. Based on rigorous physics and computational methods, we have developed quantitative magnetic resonance imaging biomarkers for precision diagnosis and treatment. Our technologies include Quantitative Susceptibility Mapping (QSMetric™), Oxygen Extraction Fraction Mapping (OEFMetric™), and Quantitative Transport Mapping (QTMetric™) as well as our robust research product QSM-MEDI™.
